Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Apnea, Obstructive | 10 | 2020 | 54 | 1.600 |
Why?
|
| Polysomnography | 9 | 2020 | 72 | 0.840 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2017 | 45 | 0.750 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 3 | 2017 | 96 | 0.710 |
Why?
|
| Continuous Positive Airway Pressure | 4 | 2009 | 15 | 0.690 |
Why?
|
| Sleep | 3 | 2017 | 316 | 0.670 |
Why?
|
| Actigraphy | 2 | 2017 | 95 | 0.590 |
Why?
|
| Monitoring, Ambulatory | 1 | 2009 | 13 | 0.330 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2009 | 31 | 0.330 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2009 | 16 | 0.330 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2009 | 177 | 0.320 |
Why?
|
| Hospitals, Public | 1 | 2007 | 25 | 0.280 |
Why?
|
| Hospitals, Urban | 1 | 2007 | 31 | 0.280 |
Why?
|
| Middle Aged | 15 | 2018 | 8403 | 0.280 |
Why?
|
| Patient Compliance | 1 | 2007 | 148 | 0.260 |
Why?
|
| Rhinitis | 2 | 2018 | 131 | 0.250 |
Why?
|
| Sinusitis | 2 | 2018 | 144 | 0.250 |
Why?
|
| Female | 17 | 2020 | 14273 | 0.240 |
Why?
|
| Body Mass Index | 6 | 2020 | 419 | 0.230 |
Why?
|
| Male | 14 | 2018 | 13917 | 0.210 |
Why?
|
| Microvascular Angina | 1 | 2002 | 1 | 0.200 |
Why?
|
| Chronobiology Disorders | 1 | 2002 | 14 | 0.190 |
Why?
|
| Hypertension | 2 | 2007 | 201 | 0.190 |
Why?
|
| Minority Groups | 1 | 2002 | 82 | 0.180 |
Why?
|
| Humans | 18 | 2020 | 25692 | 0.180 |
Why?
|
| Melatonin | 1 | 2002 | 120 | 0.180 |
Why?
|
| Sepsis | 1 | 2002 | 119 | 0.180 |
Why?
|
| Diabetes, Gestational | 1 | 2020 | 8 | 0.180 |
Why?
|
| Obesity | 2 | 2005 | 290 | 0.170 |
Why?
|
| Pregnancy Complications | 1 | 2020 | 46 | 0.170 |
Why?
|
| Severity of Illness Index | 5 | 2011 | 913 | 0.160 |
Why?
|
| Blood Glucose | 3 | 2020 | 104 | 0.160 |
Why?
|
| Nocturnal Myoclonus Syndrome | 1 | 2018 | 2 | 0.150 |
Why?
|
| Habits | 1 | 2017 | 3 | 0.140 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 47 | 0.140 |
Why?
|
| Prospective Studies | 6 | 2017 | 1633 | 0.140 |
Why?
|
| Obesity, Morbid | 2 | 2007 | 87 | 0.130 |
Why?
|
| Kidney | 1 | 2017 | 155 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 78 | 0.130 |
Why?
|
| Sleep, REM | 2 | 2020 | 15 | 0.130 |
Why?
|
| Comorbidity | 3 | 2018 | 457 | 0.120 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 140 | 0.120 |
Why?
|
| Adult | 7 | 2020 | 7336 | 0.120 |
Why?
|
| Prevalence | 2 | 2009 | 435 | 0.120 |
Why?
|
| Odds Ratio | 2 | 2018 | 244 | 0.110 |
Why?
|
| Splenic Neoplasms | 1 | 1993 | 4 | 0.110 |
Why?
|
| Hemangioma | 1 | 1993 | 6 | 0.110 |
Why?
|
| Pleural Effusion, Malignant | 1 | 1993 | 3 | 0.110 |
Why?
|
| Dyspnea | 1 | 1993 | 37 | 0.110 |
Why?
|
| Illinois | 2 | 2017 | 223 | 0.100 |
Why?
|
| Cohort Studies | 3 | 2018 | 1781 | 0.100 |
Why?
|
| Chicago | 2 | 2016 | 869 | 0.090 |
Why?
|
| Aged | 5 | 2018 | 8501 | 0.090 |
Why?
|
| Behavior Therapy | 1 | 2011 | 79 | 0.090 |
Why?
|
| Ondansetron | 1 | 2010 | 1 | 0.090 |
Why?
|
| Serotonin Antagonists | 1 | 2010 | 7 | 0.090 |
Why?
|
| Fluoxetine | 1 | 2010 | 33 | 0.090 |
Why?
|
| Cross-Over Studies | 1 | 2009 | 63 | 0.080 |
Why?
|
| Risk Factors | 3 | 2020 | 2224 | 0.080 |
Why?
|
| Equipment Design | 1 | 2009 | 139 | 0.080 |
Why?
|
| Age Distribution | 1 | 2009 | 84 | 0.080 |
Why?
|
| Recurrence | 1 | 2009 | 275 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 443 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2009 | 392 | 0.070 |
Why?
|
| Alanine Transaminase | 1 | 2007 | 14 | 0.070 |
Why?
|
| United States Food and Drug Administration | 1 | 2007 | 22 | 0.070 |
Why?
|
| Fatty Liver | 1 | 2007 | 30 | 0.070 |
Why?
|
| Gastroplasty | 1 | 2007 | 22 | 0.070 |
Why?
|
| Algorithms | 1 | 2009 | 347 | 0.070 |
Why?
|
| Insurance, Health | 1 | 2007 | 20 | 0.070 |
Why?
|
| Demography | 1 | 2007 | 66 | 0.070 |
Why?
|
| Liver | 1 | 2007 | 144 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2018 | 3220 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2007 | 98 | 0.070 |
Why?
|
| Laparoscopy | 1 | 2007 | 170 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2018 | 403 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2005 | 129 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2016 | 3231 | 0.050 |
Why?
|
| Young Adult | 2 | 2020 | 1855 | 0.050 |
Why?
|
| United States | 2 | 2007 | 1943 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2020 | 39 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2002 | 266 | 0.040 |
Why?
|
| Adolescent | 2 | 2020 | 2076 | 0.040 |
Why?
|
| Logistic Models | 1 | 2020 | 366 | 0.040 |
Why?
|
| Pregnancy | 1 | 2020 | 291 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 532 | 0.040 |
Why?
|
| Quality of Life | 2 | 2016 | 600 | 0.040 |
Why?
|
| Snoring | 1 | 2017 | 2 | 0.040 |
Why?
|
| Sleep Deprivation | 1 | 2017 | 72 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2016 | 53 | 0.030 |
Why?
|
| Insulin Resistance | 2 | 2007 | 49 | 0.030 |
Why?
|
| Health Behavior | 1 | 2016 | 136 | 0.030 |
Why?
|
| Research Design | 1 | 2016 | 188 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 164 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 847 | 0.030 |
Why?
|
| Time Factors | 1 | 2016 | 1336 | 0.030 |
Why?
|
| Mood Disorders | 1 | 2011 | 27 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2011 | 32 | 0.020 |
Why?
|
| Fatigue | 1 | 2011 | 55 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 256 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 207 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 163 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 325 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2010 | 396 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 560 | 0.020 |
Why?
|
| Hepatitis | 1 | 2007 | 5 | 0.020 |
Why?
|
| Dehydration | 1 | 2007 | 3 | 0.020 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2007 | 21 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2007 | 17 | 0.020 |
Why?
|
| Metabolic Syndrome | 1 | 2007 | 60 | 0.020 |
Why?
|
| Weight Loss | 1 | 2007 | 105 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2007 | 166 | 0.020 |
Why?
|
| Length of Stay | 1 | 2007 | 300 | 0.020 |
Why?
|
| Glycemic Index | 1 | 2005 | 2 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 1300 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 1689 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2005 | 271 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2007 | 827 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2005 | 1077 | 0.010 |
Why?
|